Skip to main content

HomeResearchFGF-1

CategorySkin & Joint
SafetyMedium Risk
StatusResearch Only

FGF-1

Fibroblast Growth Factor 1 · acidic FGF · aFGF

CategorySkin & Joint
Half-life
Routetopical, subcutaneous
RiskMedium Risk
ProvidersNone listed

About FGF-1

Binds all four FGFR subtypes (broadest binding of FGF family). Activates MAPK and PI3K downstream pathways. Promotes fibroblast proliferation, angiogenesis, and hair follicle cycling into anagen phase.

A member of the fibroblast growth factor family that promotes cell growth, tissue repair, and angiogenesis across multiple cell types. Studied for wound healing, hair follicle stimulation, and skin rejuvenation.

Research Areas

wound healinghair growth supportskin repairangiogenesis

Regulatory & Evidence

Risk Profile

Medium Risk

Moderate risk profile in research contexts. Review contraindications and administration guidelines before use.

Regulatory Status

Availability Status
Research Only

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Safety Notes

Medium Risk

Moderate risk profile. Review all reported considerations carefully before use.

Reported contraindications & considerations

Active Cancer HistoryPregnant Or Nursing

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Where to Find FGF-1

Coverage expanding

No verified providers currently list FGF-1. Get notified when one does, or explore providers carrying similar peptides in the Skin & Joint category.

Frequently Asked Questions — FGF-1

A member of the fibroblast growth factor family that promotes cell growth, tissue repair, and angiogenesis across multiple cell types. Studied for wound healing, hair follicle stimulation, and skin rejuvenation.

wound healing, hair growth support, skin repair, angiogenesis, fibroblast activation.

Newsletter

The Peptide Research Digest

New providers, emerging stacks, and research developments — weekly.

No spam. Unsubscribe anytime. Privacy policy.